Insmed (INSM) News Today $77.99 +0.30 (+0.39%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$77.98 -0.01 (-0.01%) As of 03/28/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Pictet Asset Management Holding SA Grows Position in Insmed Incorporated (NASDAQ:INSM)Pictet Asset Management Holding SA grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 5.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,959,718 shares of the biopharmaceutical company'sMarch 30 at 5:36 AM | marketbeat.comPrudential Financial Inc. Grows Position in Insmed Incorporated (NASDAQ:INSM)Prudential Financial Inc. raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,722 shares of the biopharmaceutMarch 30 at 4:24 AM | marketbeat.comVanguard Group Inc. Has $1.26 Billion Stock Position in Insmed Incorporated (NASDAQ:INSM)Vanguard Group Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,218,973 shares of the biopharmaMarch 29 at 4:28 AM | marketbeat.comKLP Kapitalforvaltning AS Acquires Shares of 33,000 Insmed Incorporated (NASDAQ:INSM)KLP Kapitalforvaltning AS bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 33,000 shares of the biopharmaceutical company's stock, valued atMarch 29 at 4:20 AM | marketbeat.comLoomis Sayles & Co. L P Has $81.11 Million Stock Position in Insmed Incorporated (NASDAQ:INSM)Loomis Sayles & Co. L P lessened its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,174,791 shares of the biopharmaceutical company's stock after selling 35,March 28 at 6:49 AM | marketbeat.comArtisan Partners Limited Partnership Raises Holdings in Insmed Incorporated (NASDAQ:INSM)Artisan Partners Limited Partnership increased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,126,339 shares of the biopharmaceMarch 28 at 6:06 AM | marketbeat.comBanco BTG Pactual S.A. Buys New Position in Insmed Incorporated (NASDAQ:INSM)Banco BTG Pactual S.A. purchased a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 8,240 shares of the biopharmaceutical company's stock, valued at approximaMarch 27, 2025 | marketbeat.comSei Investments Co. Acquires 29,019 Shares of Insmed Incorporated (NASDAQ:INSM)Sei Investments Co. raised its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 362,616 shares of the biopharmaceutical company's stock after buying an additional 29,019March 27, 2025 | marketbeat.comAmerican Century Companies Inc. Has $56.11 Million Stake in Insmed Incorporated (NASDAQ:INSM)American Century Companies Inc. grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 812,780 shares of thMarch 27, 2025 | marketbeat.comCorient Private Wealth LLC Has $1.02 Million Position in Insmed Incorporated (NASDAQ:INSM)Corient Private Wealth LLC lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 34.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,730 shares of the biopharmaceutical company's stock after acquiriMarch 27, 2025 | marketbeat.comEFG Asset Management North America Corp. Buys 56,758 Shares of Insmed Incorporated (NASDAQ:INSM)EFG Asset Management North America Corp. raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 111.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,625 shares of tMarch 26, 2025 | marketbeat.comTeacher Retirement System of Texas Grows Position in Insmed Incorporated (NASDAQ:INSM)Teacher Retirement System of Texas lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 24.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 48,337 shares of the biopharmaceutical company's stock after purchasing an additioMarch 26, 2025 | marketbeat.comIs Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street AnalystsMarch 25, 2025 | msn.comInsmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International ConferenceMarch 25, 2025 | prnewswire.comWells Fargo Sticks to Their Buy Rating for Insmed (INSM)March 24, 2025 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) is Emerald Advisers LLC's 6th Largest PositionEmerald Advisers LLC decreased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 0.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 684,636 shares of the biopharmaceutical company's stock after selling 5,171 sharesMarch 24, 2025 | marketbeat.comSimplify Asset Management Inc. Invests $1.42 Million in Insmed Incorporated (NASDAQ:INSM)Simplify Asset Management Inc. bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 20,520 shares of the biopharmaceutical company's stock, valued at apprMarch 24, 2025 | marketbeat.comCibc World Markets Corp Purchases New Stake in Insmed Incorporated (NASDAQ:INSM)Cibc World Markets Corp acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 16,135 shares of the biopharmaceutical company's stock, vaMarch 23, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $96.00 at Bank of AmericaMarch 23, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) Given Average Rating of "Buy" by AnalystsShares of Insmed Incorporated (NASDAQ:INSM - Get Free Report) have been given a consensus rating of "Buy" by the sixteen ratings firms that are covering the stock, MarketBeat.com reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1 year price target amonMarch 23, 2025 | marketbeat.comInsmed's (INSM) Outperform Rating Reiterated at Royal Bank of CanadaMarch 22, 2025 | americanbankingnews.comInsmed price target raised to $96 from $92 at BofAMarch 21, 2025 | markets.businessinsider.comBank of America Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) StockBank of America raised their price target on Insmed from $92.00 to $96.00 and gave the company a "buy" rating in a research note on Thursday.March 21, 2025 | marketbeat.comWilliam Lewis Sells 18,750 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $77.03, for a total value of $1,444,312.50. Following the transaction, the chief executive officer now owns 334,186 shares of the company's stock, valued at approximately $25,742,347.58. This represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 21, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CEO Sells $1,444,312.50 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $77.03, for a total transaction of $1,444,312.50. Following the transaction, the chief executive officer now directly owns 334,186 shares in the company, valued at $25,742,347.58. The trade was a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 20, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Earns Outperform Rating from Royal Bank of CanadaRoyal Bank of Canada reissued an "outperform" rating and set a $100.00 target price on shares of Insmed in a research note on Wednesday.March 20, 2025 | marketbeat.comIntech Investment Management LLC Raises Stock Position in Insmed Incorporated (NASDAQ:INSM)Intech Investment Management LLC grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 52.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 71,227 shares of theMarch 20, 2025 | marketbeat.comProficio Capital Partners LLC Acquires Shares of 26,995 Insmed Incorporated (NASDAQ:INSM)Proficio Capital Partners LLC acquired a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 26,995 shares of the biopharmaceutical company's stock, valued at appMarch 20, 2025 | marketbeat.com3INSM : Expert Outlook: Insmed Through The Eyes Of 13 AnalystsMarch 19, 2025 | benzinga.comInsmed (INSM) Gets a Buy from Mizuho SecuritiesMarch 19, 2025 | markets.businessinsider.comRoyce & Associates LP Sells 5,000 Shares of Insmed Incorporated (NASDAQ:INSM)Royce & Associates LP decreased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 90,027 shares of the biopharmaceutical company's stock afMarch 19, 2025 | marketbeat.comInsmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to BillionairesMarch 18, 2025 | msn.comWilliam Blair Investment Management LLC Grows Position in Insmed Incorporated (NASDAQ:INSM)William Blair Investment Management LLC increased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,433,443 shares of the biopharmaceutical company's stock after buMarch 18, 2025 | marketbeat.comSwiss National Bank Has $22.17 Million Stake in Insmed Incorporated (NASDAQ:INSM)Swiss National Bank raised its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 321,100 shares of the biopharmaceutical company's stock after purchasing anMarch 18, 2025 | marketbeat.comIs Insmed Incorporated (INSM) a Best Biotech Stock According to Billionaires?March 17, 2025 | insidermonkey.comJ.P. Morgan Sticks to Their Buy Rating for Insmed (INSM)March 17, 2025 | markets.businessinsider.comPicton Mahoney Asset Management Has $3.37 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Picton Mahoney Asset Management increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,897 shares of the biopharmaceuMarch 17, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Catalyst Funds Management Pty LtdCatalyst Funds Management Pty Ltd boosted its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 60.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,250 shares of the biopharmaceutical company's stock after acquiring an additionaMarch 16, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Increases Stock Position in Insmed Incorporated (NASDAQ:INSM)Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 18.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 43,476 shares of the biopharmaceutical company's stock after acquiring an addiMarch 16, 2025 | marketbeat.comInsmed (INSM) Gets a Buy from GuggenheimMarch 13, 2025 | markets.businessinsider.comVictory Capital Management Inc. Sells 45,382 Shares of Insmed Incorporated (NASDAQ:INSM)Victory Capital Management Inc. trimmed its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 410,577 shares of the biopharmaceutical company's stock after seMarch 11, 2025 | marketbeat.comEssex Investment Management Co. LLC Decreases Stake in Insmed Incorporated (NASDAQ:INSM)Essex Investment Management Co. LLC reduced its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 67,330 shares of the biopharmaceutical comMarch 10, 2025 | marketbeat.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)March 10, 2025 | prnewswire.comEdgestream Partners L.P. Has $3.01 Million Stock Position in Insmed Incorporated (NASDAQ:INSM)Edgestream Partners L.P. lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 1,242.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,619 shares of the biopharmaceutical company's stock after purchasing aMarch 10, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,546,607 shares of thMarch 9, 2025 | marketbeat.comInsmed assumed with an Overweight at Morgan StanleyMarch 7, 2025 | markets.businessinsider.comInsmed (NASDAQ:INSM) Given New $110.00 Price Target at UBS GroupUBS Group lifted their target price on Insmed from $105.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday.March 7, 2025 | marketbeat.comProficio Capital Partners LLC Makes New $1.86 Million Investment in Insmed Incorporated (NASDAQ:INSM)Proficio Capital Partners LLC purchased a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 26,995 shares of the biopharmaceutical company's stockMarch 7, 2025 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 18,750 Shares of StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $77.79, for a total transaction of $1,458,562.50. Following the sale, the chief executive officer now owns 334,186 shares in the company, valued at $25,996,328.94. This represents a 5.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.March 6, 2025 | marketbeat.comInsmed price target raised to $110 from $105 at UBSMarch 6, 2025 | markets.businessinsider.com Remove Ads Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼1.380.82▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼1810▲INSM Articles Average Week Remove Ads Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Beigene News Today Royalty Pharma News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today United Therapeutics News Today Intra-Cellular Therapies News Today BioMarin Pharmaceutical News Today Genmab A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
